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PRIMARY RADIATION THERAPY OR SURGERY COMBINED OR NOT TO RADIATION THERAPY IN THE MANAGEMENT OF 
SQUAMOUS CELL CARCINOMA OF THE PENIS 
Abderrahim Zoohair, MD, Mahmut Ozsahin, MD, PhD; Pelham Douglas, MD; Philippe A. Coo&e, MD; and Rent 0. Mirimmoff, MD 
Department of Radiation Oncology, Laosanne University Medical Center (CHUV), Lausanne, Switzerland. 
Purpose: To assess the prognostic factors and the outcome in patients with squamqus cell carcinoma of 
the penis. 
Mat&z/s & Mefhods: A retrospective review of 41 consecutive patients with non-metastatic invasive 
carcinoma of the penis, treated between 1962 and 1994, was perforrr~ed. The median age was 59 years 
(range: 35-76). Eight (20%) patients were circumcised, 30 (73%) were. married, and only 2 (5%) had a 
history of venereal disease. Existence of a penile mass was the. fast symptom in 32 (78%) patients. The 
anatomic site was distributed as follows: glans in 17 (41%). prepuce in 9 (22%). shaft in 8 (20%). 
coronary IwaIization in 4 (10%). prepuce and glans in 2 (5%). and shaft and prepuce in 1 (2%). According 
to UICC staging, there were 12 (29%) Tl, 24 (59%) T2.4 (10%) ‘B, and 1 TX (2%) tumors. The N-stage 
was distributed as foIlows: 29 (71%) patients with NO, 8 (20%) with Nl, 3 (7%) with N2, and 1(2%) with 
M. Ihin (32%) patients had grade 1. 7 grade 2, and 9 grade 3 hmmrs (grade was determined in 12). 
Fatty-four percent (n = 18) of the patients underwent a curative surgery: partial penectomy with (n = 4) or 
without (n = 12) lymph node dissection. or total penectomy with (n = 1) or without (n = 1) lymph node 
dissection. AI1 but 4 patients (operated) underwent primary (n = 23) or postoperative (n = 14) radiotherapy 
to the penis and inguinal lymph nodes (n = 20). penis alone (n = 9), or inguinal lymph nodes alone (n = 8). 
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Results: In a median pe>od of 12 months (range: 5-139), 63% (n = 26) of the patients relapsed (local in 
18. locoreeional in 2. reaional in 3. and distant in 3). Local failure was observed in 4 out of 16 125%) 
patients t&&d with &&I penecto~y f postopera& radiotherapy vs. in 14 out of 23 (61%) treated wi& 
primary radiotherapy (p = 0.06). Fifteen (83%) out of 18 local failures were successfully salvaged with 
surgery. At the time of analysis, among the 23 patients treated with primary radiotherapy. local control 










patients. In all patients, 5: and lo-year ca&-spdcific and disease-free s&&i (Kaplan-M&r product: 
limit estimates) was 57% and 49%, and 38% and 26%, respecrively. l’be 5- and IO- year local and 
Iworegional relapse rate was 43% and 6I%, and 52% and 67%. respectively. In patients treated with 
primary radiotherapy, S- and lo-year probability of surviving with penis was 36% and 18%. respectively. 
In multivariate analyses (Cox model), statistically significant factors influencing the local control were the 
clinical N-stage (NO, I vs. N2,3; p = 0.05) and surgery (curative surgery vs. primary radiotherapy; p = 
0.02). Surgery was the only independent factor predicting tbe locoregional control @ = 0.01). On the other 
hand, cause-specific survival was influenced only by the clinical N-stage (NO,1 YS. N2,3; p = 0.03). 
a I . 6 Conclusions: We conclude that. in patients with squamous cell carcinoma of the penis, local relapse rate 
24 48 72 96 120 is lower in patients treated with surgery. However, there appears to be no difference in temu of survival 
months between patients treated by surgery and those treated by primary radiotherapy * salvage surgery, with a 
39% probability of organ preservation. 
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EFFICACY OF ADJUVANT PELVIC AND HIGH DOSE RATE INTRACAVITARY RADIATION IN PATIENTS WITH 
INTERMEDIATE TO HIGH RISK ENDOMETRIAL CANCER 
E.A. Dunphy,’ D.G. Petereit’,‘, J.C. S&ink’, E.A. Grosen’, E.M. Hartenbach’ and D A. Duchler’~’ 
University of Wisconsin School of Medicine: ’ 
Wisconsin 53792 
Department of Human Oncology, ‘Department of Gynecology, Madison, 
Purpose/Objective: To determine the efficacy of adjuvant whole pelvic radiation (WPRT) in combination with high dose rate 
(HDR) vaginal cuff brachytherapy (VCB) in patients with intermediate to high risk endometrial cancer. 
Material & Methods: From 4/23/YO to S/6/96, forty-three patients with intermediate to high risk endomrtrial cancer 
received adjuvant radiation beginning 4 to b weeks after surgery. The following stages of d~scnse were treated- 
Stage IC (7 pts), Stage IIA (10 p’s), Stage 116 (15 p’s), Stage IllA (8 pts) and Stage IIIC (2 pts). 
Stage IB (1 pt), 
I‘atients hxl the f~~llowng 
hlstologies: grade 1 adenocarcinoma (14 p’s), grade 2 adenocarcinoma (lb p’s), grade 3 adenocarcinoma (8 pts), grade 2 
adenosquamous carcinoma (1 p’), papillary serous adenocarcinoma (2 pts), papillary serous and clear cell adcla,carcinomd (1 
pt) and clear cell adenocarcinoma (1 pt). Patients were treated with WPRT with a median dose of 51 Cy (1.7 Cy/Fx), in 
conjunction with 2 HDR VCB insertions utilizing avoids where the dose was prescribed to the vagmal surface at 7 8 Gy/Fx 
(LDR equivalent of 20 Gy at 100 cGy/h). One patient with Stage IIIA disease had para-aortic radiation to 5Y.5 Gy in 35 
fractions. Surgety consisted of a TAH/BSO with an assessment of the pelvic lymph ~mdes in lY’%,, pelvic/pars-aortic lymph 
nodes in 28”ht and/or peritoneal cytology in 37% of patients. The majority of patients treated it1 this study had their surgely 
elsewhere and were referred in for adjuoant radiation. Complications were scored using the RTOG 5-tiered system. Three year 
clinical endpoints were calculated using the Kaplan Meier method. 
Results: With a median follow-up time of 27 months (4 - 8b months range), the 3 year survival and relapse-free survival (RFS) 
were 89% and 82%, respectively. Two patients recurred in the pelvis: one in the lower l/3 vaglne (4 years after initial 
treatment) and the second along the entire vagina (both had synchronous distant metastases). One pattent develqxd an 
isolated para-aortic recurrence. Seven patients had distant recurrences nt the f&owing sites: lung and colon (I), lung amI 
vagina (2). bone and para-aortics (I), adrenal (1). biliary duct and inguinal lymph nodes (I) and peritoneum (I). All three 
patients with papillary serous histologies had an upper abdominal recurrence (colon, hiliary duct and peritoneum). There was r\ 
single grade 3 small bowel complication that was treated medIcally. 
Conclusion: Adjuvant whole pelvic and HDR intracavitary radiation produced excellent pelvic control rates (c)7’>;, at 3 years) 
wth nwumal late toxicities in patients with intermedrate to lueh risk endometrial cancer. More ncrcresswe theraov. such as ,,” 1 I. 
extended field irradiation, may have reduced the upper abdominal rc’currcnces in p.,tiellts with pnpillnry serous (I’S) histologies, 
but was not delivered because of medical contraindications to whole abd,uninal radiation. In the other upper abdominal 
recurrences observed (non-I’s histology), extended field radmtion may have prevented the development of these sites of disease. 
Complete surgical evaluation might identify such patients who may benefit from more comprehensive radiation fields. Overall, 
the excellent pelvic control with a 3 year RPS of R2’K, indicates the efficacy of adplv,“‘t radiation for yaticnts who have a 
intermediate to high risk for recurrence withuu~ additional therapy. Finally, the vaginal cuff boost rvith I IDR br.lchytherapy was 
well tolerated and did not appear to produce additional complications 
responsible for the excellent central control rates in this study. 
The IHDK VCB boost may have been partially 
